Cleared Traditional

K221704 - HemoSphere Advanced Monitor

K221704 is an FDA 510(k) clearance for HemoSphere Advanced Monitor, manufactured by Edwards Lifesciences, LLC. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 162-day FDA review.

K221704 · Edwards Lifesciences, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2022
Decision
162d
Days
Class 2
Risk

K221704 is an FDA 510(k) clearance for the HemoSphere Advanced Monitor, Right Ventricular Pressure (RVP), Global Hypoper.... Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Edwards Lifesciences, LLC (Irvine, US). The FDA issued a Cleared decision on November 22, 2022 after a review of 162 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Edwards Lifesciences, LLC devices

FDA 510(k) Submission Details - K221704

510(k) Number K221704 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 13, 2022
Decision Date November 22, 2022
Days to Decision 162 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
37d slower than avg
Panel avg: 125d · This submission: 162d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 268
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K221704.
EndoPATx
K211557 · Itamar Medical , Ltd. · Dec 2022
EnSite™ X EP System TactiFlex™ Ablation Catheter, Sensor Enabled™, Software Upgrade
K223094 · Abbott Medical · Dec 2022
STAR Apollo Mapping System
K220786 · Rhythm Al, Ltd. · Dec 2022
HemoSphere Advanced Monitoring Platform, HemoSphere ForeSight Oximeter cable
K223127 · Edwards Lifeciences, LLC · Nov 2022
KODEX – EPD™ System 1.5.0
K212493 · Philips Medical Systems Nederland, B.V. (Pmsn) · Oct 2022
AcQMap High Resolution Imaging and Mapping System
K222209 · Acutus Medical, Inc. · Oct 2022